Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
9.08
-2.08 (-18.64%)
At close: Nov 13, 2026, 4:00 PM EST
9.15
+0.07 (0.77%)
Pre-market: Nov 16, 2026, 8:14 AM EST
Zevra Therapeutics Employees
Zevra Therapeutics had 61 employees as of December 31, 2025. The number of employees increased by 2 or 3.39% compared to the previous year. That makes Zevra Therapeutics the 34,173rd largest employer in the world and 4,515th in the United States.
Employees
61
Change (1Y)
2
Growth (1Y)
3.39%
Revenue / Employee
$2,422,361
Profits / Employee
$1,229,066
Market Cap
540.30M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 61 | 2 | 3.39% | 61 | 0 |
| Dec 31, 2024 | 59 | -10 | -14.49% | 59 | 0 |
| Dec 31, 2023 | 69 | 33 | 91.67% | 65 | 4 |
| Dec 31, 2022 | 36 | 12 | 50.00% | 32 | 4 |
| Dec 31, 2021 | 24 | 2 | 9.09% | 24 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Valneva SE | 620 |
| REGENXBIO | 371 |
| Capricor Therapeutics | 231 |
| Sana Biotechnology | 142 |
| Neurogene | 131 |
| Orchestra BioMed Holdings | 86 |
| Crescent Biopharma | 69 |
| Eupraxia Pharmaceuticals | 49 |
ZVRA News
- 34 minutes ago - Zevra Therapeutics price target lowered to $18 from $23 at Guggenheim - TheFly
- 3 days ago - Zevra reports European negative opinion on MAA for arimoclomol - TheFly
- 3 days ago - Zevra Therapeutics Announces Final CHMP Opinion on Arimoclomol for the Treatment of Niemann-Pick Disease Type C (NPC) in the European Union - GlobeNewsWire
- 12 days ago - Zevra Therapeutics reports Q3 EPS 26c, consensus 18c - TheFly
- 12 days ago - Zevra Therapeutics Earnings Call Transcript: Q3 2026 - Transcripts
- 12 days ago - Zevra Therapeutics Earnings release: Q3 2026 - Filings
- 12 days ago - Zevra Therapeutics Quarterly report: Q3 2026 - Filings
- 12 days ago - Zevra Reports Third Quarter 2026 Financial Results and Corporate Update - GlobeNewsWire